Elanco
Elanco Animal Health Incorporated, commonly known as Elanco, is a leading global animal health company headquartered in the United States. Founded in 1954, Elanco has established itself as a key player in the animal health industry, focusing on innovative solutions for both livestock and companion animals. With a strong presence in North America, Europe, and Asia, the company offers a diverse range of products and services, including pharmaceuticals, vaccines, and nutritional products. Elanco's commitment to improving animal health and welfare is evident in its unique offerings, which are designed to enhance productivity and sustainability in animal agriculture. The company has achieved notable milestones, including the launch of several groundbreaking products that address critical health challenges in animals. As a trusted partner in the animal health sector, Elanco continues to strengthen its market position through research and development, ensuring a healthier future for animals and the people who care for them.
DitchCarbon Score
How does Elanco's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Elanco's score of 41 is higher than 94% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Elanco's reported carbon emissions
In 2023, Elanco reported total carbon emissions of approximately 430,209,000 kg CO2e, comprising 145,020,000 kg CO2e from Scope 1 and 285,188,000 kg CO2e from Scope 2 emissions. Additionally, Scope 3 emissions were significant, amounting to 624,083,000 kg CO2e, primarily from purchased goods and services. Elanco has made a commitment to achieve net-zero emissions across all scopes by 2050, aligning with the Science Based Targets initiative (SBTi). This long-term target reflects the company's dedication to reducing its carbon footprint and addressing climate change comprehensively. Over recent years, Elanco has demonstrated a trend of decreasing emissions, with a notable reduction from 1,101,000,000 kg CO2e in 2021 to 1,017,744,000 kg CO2e in 2022. This reduction showcases their ongoing efforts to enhance sustainability practices within their operations. Elanco's climate commitments and emissions data underscore its proactive approach to environmental stewardship, aiming to contribute positively to global climate goals while maintaining operational efficiency.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 274,550,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 418,271,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Elanco is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
